A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin and Ezetimibe

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The objective of this study is to evaluate the potential PK interaction between ABT-335, atorvastatin 80 mg and ezetimibe 10 mg when administered concurrently.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Abbott
• Treatments: Atorvastatin; Atorvastatin Calcium; Ezetimibe; Fenofibric acid

Criteria

Inclusion Criteria:

• Healthy male or female subjects

Exclusion Criteria:

• Clinically significant diseases or disorders

• Positive screens for drug and alcohol

• Pregnant or breast-feeding females

• Any history of surgery(ies) that might interfere with the gastrointestinal motility, pH or absorption